Total Payments
$29,352
2022 Payments
$1,350
Companies
16
Transactions
68
Medicare Patients
668
Medicare Billing
$41,785
Payment Breakdown by Category
Other$28,684 (97.7%)
Food & Beverage$612.58 (2.1%)
Education$55.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $28,684 | 16 | 97.7% |
| Food and Beverage | $612.58 | 47 | 2.1% |
| Education | $55.00 | 1 | 0.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$29,352
64 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Great Lakes Medical Services, LLC | $28,684 | 20 | $0 (2022) |
| Astellas Pharma US Inc | $291.29 | 24 | $0 (2021) |
| AbbVie, Inc. | $82.37 | 5 | $0 (2019) |
| DENTSPLY IH Inc. | $35.87 | 3 | $0 (2019) |
| Allergan Inc. | $35.42 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $34.68 | 2 | $0 (2018) |
| Boston Scientific Corporation | $34.00 | 2 | $0 (2019) |
| PFIZER INC. | $23.98 | 2 | $0 (2018) |
| Amgen Inc. | $20.97 | 1 | $0 (2019) |
| Cook Medical LLC | $18.80 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,350 | 1 | Great Lakes Medical Services, LLC ($1,350) |
| 2021 | $1,875 | 5 | Great Lakes Medical Services, LLC ($1,846) |
| 2020 | $4,149 | 4 | Great Lakes Medical Services, LLC ($4,149) |
| 2019 | $8,747 | 11 | Great Lakes Medical Services, LLC ($8,641) |
| 2018 | $7,517 | 35 | Great Lakes Medical Services, LLC ($7,104) |
| 2017 | $5,714 | 12 | Great Lakes Medical Services, LLC ($5,594) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2022 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Stock option | $1,350.00 | General |
| 10/15/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/19/2021 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $90.00 | General |
| 02/19/2021 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $6.00 | General |
| 01/25/2021 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Stock option | $1,750.00 | General |
| 02/24/2020 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $124.00 | General |
| 02/24/2020 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $25.00 | General |
| 01/23/2020 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Stock option | $4,000.00 | General |
| 2020 | Great Lakes Medical Services, LLC | — | — | — | $0.00 | Ownership |
| 11/14/2019 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Medical Urology | ||||||
| 08/20/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/27/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/02/2019 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Bone Health | ||||||
| 03/26/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: THERAPIES | ||||||
| 03/01/2019 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $124.00 | General |
| 03/01/2019 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $17.00 | General |
| 02/27/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Endocrinology | ||||||
| 02/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: UROLOGY | ||||||
| 01/24/2019 | Great Lakes Medical Services, LLC | — | Current or prospective ownership or investment interest | Stock option | $8,500.00 | General |
| 2019 | Great Lakes Medical Services, LLC | — | — | — | $0.00 | Ownership |
| 12/13/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Endocrinology | ||||||
| 12/11/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: UROLOGY | ||||||
| 12/06/2018 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 13 | 668 | 808 | $180,114 | $41,785 |
Total Patients
668
Total Services
808
Medicare Billing
$41,785
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 69 | 78 | $44,128 | $10,748 | 24.4% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2020 | 17 | 20 | $23,995 | $6,825 | 28.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 75 | $17,128 | $5,315 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 51 | 88 | $16,978 | $5,019 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 95 | $14,426 | $4,266 | 29.6% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2020 | 24 | 25 | $39,894 | $3,054 | 7.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 23 | 23 | $6,308 | $1,897 | 30.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $4,410 | $1,214 | 27.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,925 | $1,102 | 37.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 18 | $2,700 | $931.93 | 34.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 216 | 282 | $2,256 | $626.60 | 27.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 14 | $1,461 | $399.59 | 27.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 60 | 65 | $3,505 | $387.70 | 11.1% |
About Dr. David Terhune, M.D
Dr. David Terhune, M.D is a Urology healthcare provider based in St. Joseph, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639157308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Terhune, M.D has received a total of $29,352 in payments from pharmaceutical and medical device companies, with $1,350 received in 2022. These payments were reported across 68 transactions from 16 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($28,684).
As a Medicare-enrolled provider, Terhune has provided services to 668 Medicare beneficiaries, totaling 808 services with total Medicare billing of $41,785. Data is available for 1 year (2020–2020), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location St. Joseph, MI
- Active Since 01/04/2006
- Last Updated 05/25/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1639157308
Products in Payments
- MYRBETRIQ (Drug) $123.19
- XTANDI (Drug) $74.29
- Lupron (Drug) $68.65
- Myrbetriq (Drug) $53.06
- LoFric (Device) $35.87
- Erleada (Drug) $34.68
- BOTOX THERAPEUTIC (Biological) $23.36
- Prolia (Biological) $20.97
- COOK MEDICAL EXTRACTORS (Device) $18.80
- Cook Medical NGage (Device) $18.58
- GENERAL THERAPIES (Device) $18.57
- GENTLECATH (Device) $16.55
- GREENLIGHT (Device) $15.43
- JELMYTO (Drug) $15.00
- INTERSTIM (Device) $14.23
- Lupron Depot (Drug) $13.72
- TOVIAZ (Drug) $12.19
- BOTOX (Biological) $12.06
- THROMBIN (Biological) $11.79
- Olympus Cystoscopes (Device) $11.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.